To Be Discontinued Nasal Spray Pulmonary/Allergy
Azelastine Hydrochloride; Fl · 383 days since initial FDA posting
Brand: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
FDA lists Azelastine Hydrochloride; Fl as To Be Discontinued (Mylan Pharmaceuticals Inc., a Viatris Company).
No availability text on this FDA row.
Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray
- Manufacturer
- Mylan Pharmaceuticals Inc., a Viatris Company
- Dosage Form
- Nasal Spray
- Presentation
- Azelastine Hydrochloride; Fluticasone Propionate, Nasal Spray, 137 ug; 50 ug (NDC 0378-3458-23)
- Package NDC
- 0378-3458-23
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Sep 4, 2025
- Last Updated
- Sep 4, 2025
- Therapeutic Category
- Pulmonary/Allergy
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
azelastine
Side effects, interactions, warnings & more
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.